Worldwide, hypoxic-ischemic encephalopathy (HIE) affects 2 million infants annually 1; it
presents clinically as neonatal encephalopathy (NE) is difficult to classify immediately after …

Data on the incidence of hypoxic-ischemic encephalopathy (HIE) in the first 6 hours of life
together with the implementation of therapeutic hypothermia (TH) are relevant to delineate …

Objective Excessive hypothermia is common in infants that receive passive cooling for
hypoxic ischemic encephalopathy (HIE). Our goal was to reduce the number of infants with …

Background In randomized clinical trials, therapeutic hypothermia (TH) has been shown to
reduce death and/or moderate-to-severe disability in neonates with hypoxic ischemic …

Objective: To characterize infants affected with perinatal hypoxic ischemic encephalopathy
(HIE) who were referred to regional neonatal intensive care units (NICUs) and their related …

Initiation of therapeutic hypothermia (TH) within 6 h of life is a major concern for treating
neonatal hypoxic ischemic encephalopathy (HIE). We aimed to determine clinical and …

Objective To quantify intercenter cost variation for perinatal hypoxic ischemic
encephalopathy (HIE) treated with therapeutic hypothermia across children's hospitals …

Background and aim The benefits of therapeutic hypothermia have not been assessed from
the perspective of the neurology clinic. We aimed to report the impact of the implementation …

Introduction There are no data on the incidence of hypoxic-ischaemic encephalopathy (HIE)
and the implementation of therapeutic hypothermia (TH) in Spain. Methods This is a cross …

In this article, we review the childhood outcomes of neonates with birth depression and/or
hypoxic-ischemic encephalopathy. The outcomes of these children prior to the era of …